As a key component of the vertebrate neuroendocrine system, the pituitary gland relies on the progressive and coordinated development of distinct hormone-producing cell types and an invading vascular network. The molecular mechanisms that drive formation of the pituitary vasculature, which is necessary for regulated synthesis and secretion of hormones that maintain homeostasis, metabolism, and endocrine function, remain poorly understood. Here, we report that expression of integrin β1 in embryonic pituitary epithelial cells is required for angiogenesis in the developing mouse pituitary gland. Deletion of pituitary epithelial integrin β1 before the onset of angiogenesis resulted in failure of invading endothelial cells to recruit pericytes efficiently, whereas deletion later in embryogenesis led to decreased vascular density and lumen formation. In both cases, lack of epithelial integrin β1 was associated with a complete absence of vasculature in the pituitary gland at birth. Within pituitary epithelial cells, integrin β1 directs a large transcriptional program that includes components of the extracellular matrix and associated signaling factors that are linked to the observed non-cell-autonomous effects on angiogenesis. We conclude that epithelial integrin β1 functions as a critical and canonical regulator of developmental angiogenesis in the pituitary gland, thus providing insight into the long-standing systems biology conundrum of how vascular invasion is coordinated with tissue development.
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angiogenesis | integrin β1 | pituitary gland | mice T he mammalian pituitary consists of glandular anterior and intermediate lobes that arise from invaginated oral ectoderm termed Rathke's pouch and a neural posterior lobe that develops in tandem as an outgrowth of the ventral diencephalon (1) . A dense vascular network delivers hypothalamic regulatory factors and target organ feedback signals that control pituitary endocrine function (2) . Angiogenesis gives rise to this network beginning on mouse embryonic day 13.5 (e13.5) as epithelial cells in the expanding anterior wall of Rathke's pouch delaminate and intercalate with invading endothelial and mesenchymal cells (3) . As embryonic blood vessels branch and spread laterally throughout the expanding anterior lobe, they form fenestrated capillaries that surround developing endocrine cells (4) . Before birth, portal vessels from the hypothalamus begin to deliver regulatory hormones, target organ feedback, and afferent blood flow to this capillary network (5) . Anterior pituitary hormones secreted in response to these signals are then delivered into the general circulation via venous drainage (6) .
Vascular development depends on integrins, a large family of glycoprotein type I transmembrane receptors that function as αβ heterodimers to mediate cell adhesion to the extracellular matrix (ECM) (7) . In turn, integrin binding to ECM affects deposition, organization, and remodeling of individual ECM components into functional supramolecular structures (8) . Integrin β1 pairs with twelve separate α-chains to form the largest integrin subfamily, and its role in vascular development has been the subject of significant investigation. Although integrin β1-null embryos died before assembly of vessel primordia (vasculogenesis), integrin β1-null teratomas and embryoid bodies suggested an endothelial cell-autonomous requirement for integrin β1 in angiogenesis [formation of new vessels from preexisting vessels (7)].
Targeted deletions proved directly that endothelial cell integrin β1 was dispensable for vasculogenesis but required for subsequent angiogenic sprouting, branching, adhesion, migration, and cell survival (9) . Later in embryogenesis, integrin β1 was necessary in arterioles for Par3-dependent endothelial cell polarity and lumen formation (10) . In postnatal retinal vasculature, integrin β1-mediated endothelial cell-ECM interactions were required for production and assembly of the ECM, as well as formation of stable, nonleaky blood vessels (11) . Mural cells (pericytes and vascular smooth muscle cells) that encase blood vessels also must express integrin β1 for adhesion and spreading, as well as assembly of ECM proteins that stabilize blood vessel walls (12, 13) .
Here, we report that expression of integrin β1 in embryonic pituitary gland epithelial cells is absolutely required for the actions of the stromal cells that constitute the developing vasculature. Based on the phenotypes of mice harboring two temporally distinct, tissuespecific disruptions of Itgb1 in embryonic pituitary gland epithelial cells, we conclude that the non-cell-autonomous function of integrin β1 is critical for pericyte recruitment, lumen formation, and persistence of the vasculature. Analysis of the epithelial cell transcriptome revealed an integrin β1-dependent gene expression program encoding ECM and associated signaling molecules that exert pleiotropic effects on the coordinated development of the pituitary gland and its invading vascular system during organogenesis.
Significance
During embryogenesis, a dense vascular network develops in the pituitary gland through the process of angiogenesis. In tandem, pituitary gland precursor cells differentiate into hormone-producing cells that will rely on the vasculature to carry out regulated endocrine function. Our data show that expression of the cell surface adhesion molecule, integrin β1, in the epithelial-derived precursor cells is required for development of the vasculature and coordinated terminal differentiation of endocrine cells. Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE89171). 
Results
Integrin β1 Is Expressed in the Pituitary Gland Throughout Embryonic Development. Integrin β1 protein was detected in all three lobes of the pituitary from e10.5 through birth, in oral ectoderm-derived epithelial cells that comprise the parenchyma of the developing gland, and in endothelial and supporting mesenchymal cells that form the vasculature (Fig. S1 A and B) . Laminin, an ECM glycoprotein that is bound by a subset of integrin β1 heterodimers, was abundant in the basement membrane that separates the epithelial tissue of the early embryonic pituitary gland from adjacent mesenchyme (3, 14) . As angiogenesis proceeds, this demarcation persists in the form of a vascular basement membrane that surrounds nascent vessels in the anterior lobe (3) (Fig. S1B) . Quantitative PCR analyses of integrin β1 mRNA in the pituitary gland from e12.5 to adulthood detected continuous low levels, with a spike in expression at postnatal day 0 (p0). Validity of these measurements was provided by quantitation of previously characterized Prop1 and prolactin (Prl) mRNAs (15) (Fig. S1C ).
Targeted Deletions of Integrin β1 in Embryonic Pituitary Gland Epithelial Cells at e10.5 and e14.5. To examine integrin β1 function in pituitary epithelial cells before cell-type differentiation or angiogenesis, we crossed Pitx1-cre transgenic mice to Itgb1 flox mice, resulting in complete loss of integrin β1 protein throughout Rathke's pouch by e10.5 (16, 17) (Fig. 1A) . To study the role of integrin β1 after the initiation of cell-type differentiation and angiogenesis, we crossed Prop1-cre transgenic mice to Itgb1 flox mice, causing progressive loss of integrin β1 protein in the parenchyma of the developing anterior and intermediate lobes that began on e13.5 and was complete by e14.5 (18) (Fig. 1B and Fig. S1D ). Importantly, coimmunostaining of integrin β1 and CD31 in Prop1-cre embryos demonstrated that expression of integrin β1 in invading endothelial cells was unaffected ( Fig. S1E ). ; Pitx1-cre mice were born in Mendelian ratios, but all mutant pups died at birth. At e15.5, hematoxylin and eosin (H&E)-stained midline sagittal sections revealed a smaller gland with a shortened pituitary cleft. By p0, the anterior and intermediate lobes were significantly smaller and displayed altered morphology, the posterior lobe was displaced in the rostral direction, there was poor anatomical definition of the intermediate lobe because of progressive shortening of the cleft, red blood cells (RBCs) were absent from the anterior lobe, and the secondary palate had failed to fuse along the midline (Fig. S2 A-D) . Itgb1 f/f ; Prop1-cre animals were born in Mendelian ratios and survived normally into adulthood. H&E staining at p2 showed signs of hemorrhage or hematoma in the lateral wings of the anterior lobes that was confirmed by microCT scans (Fig. S2 E and F) . Although H&E staining showed normal placement of the three pituitary lobes, Itgb1 f/f ; Prop1-cre pituitaries dissected at p2 revealed a decreased size of the anterior lobe that became dramatic by p25 (Fig. S2G ). Given that normal postnatal growth relies on secretion of growth hormone (GH) from anterior lobe somatotropes, we compared the weights of Itgb1 f/f ; Prop1-cre mice with the weights of Itgb1 f/f littermates in the 10-d period following weaning at p21. In four separate litters, all Itgb1 f/f ; Prop1-cre animals weighed less at each time point, and by p31, their weights were, on average, 66% of controls (Fig. S2H) . These results suggested diminished somatotrope function due to decreased expression, secretion, and/or delivery of GH.
Endocrine Cell-Type Differentiation. To assess the role of integrin β1 in endocrine cell-type differentiation, we examined expression of pituitary hormone genes. Pit-1 is a key transcription factor that is required for specification of the somatotrope, lactotrope, and thyrotrope cells that, upon terminal differentiation, express growth hormone (GH), Prl, and thyroid-stimulating hormone-β (TSH-β), respectively. These three hormone-encoding genes are also direct transcriptional targets of Pit-1, which functions in combination with hypothalamic regulatory signals and target organ feedback to achieve regulated physiological expression (15) . Although normal temporal expression of pro-opiomelanocortin (POMC) at e13.5, TSH-β at e15.5, and POMC and GH at p0 was observed, differences in spatial expression patterns were noted at each stage in Itgb1 f/f ; Pitx1-cre embryos (Fig. S3 A-C) . At p0, expression of Pit-1 mRNA was normal but GH and Prl were significantly down-regulated, whereas TSH-β was up-regulated ( Fig. S3D) . At p18, Itgb1 f/f ; Prop1-cre pituitary glands were significantly smaller, expressed less GH and Prl protein, and contained mislocalized dorsal thyrotropes (Fig.  S3E) . At p17, Pit-1 mRNA expression was normal but levels of GH and Prl were diminished (Fig. S3F) . In both Itgb1 f/f ; Pitx1-cre and Itgb1 f/f ; Prop1-cre pituitaries, normal expression of Pit-1 was combined with significantly altered expression of its target genes, suggesting that failure to receive additional critical hypothalamic regulatory signals and target organ feedback via the circulatory system might be the explanation. ; Prop1-cre pituitaries displayed a remarkable absence of CD31 immunostaining, suggesting that the entire dense network of blood vessels had failed to form and/or stabilize in the absence of epithelial integrin β1 (Fig. 2A) . This result was verified with a second, independent endothelial cell marker, PLVAP (plasmalemmal vesicle-associated protein) (19) (Fig. 2B) . Coimmunostaining of CD31 and laminin showed lamininrich vascular basement membranes in control animals but failed to detect laminin-rich "empty basement membrane sleeves" in either Itgb1 f/f ; Pitx1-cre or Itgb1 f/f ; Prop1-cre pituitary glands, suggesting that even if vessels had formed, they had been absent for several days (20) (Fig. S4A) . Coimmunostaining of integrin β1 and laminin (Fig. S4B) .
Angiogenesis Begins at e13.5 but Invading Endothelial Cells Fail to Recruit Pericytes in Itgb1 f/f ; Pitx1-cre Pituitaries. To assess how the initial steps in angiogenesis proceeded in the absence of epithelial integrin β1, we examined Itgb1 f/f ; Pitx1-cre pituitaries at e13.5, the time point at which we observed angiogenesis beginning in the anterior lobe. CD31 and integrin β1(+) endothelial cells were present in control and Itgb1 f/f ; Pitx1-cre pituitaries (Fig. S5A) . Coimmunostaining with CD31 and laminin revealed that they deposited laminin-rich basement membranes at e13.5. By e14.5, however, neither endothelial cells nor their basement membranes were detected in Itgb1 f/f ; Pitx1-cre pituitaries (Fig. S5B) . To determine whether lumen formation was related to the disappearance of endothelial cells, we looked for evidence of RBCs using H&E staining. In both control and Itgb1 f/f ; Pitx1-cre embryos at e13.5, RBCs were present in vessels surrounding the pituitary but were not detected within the gland, suggesting that lumen formation begins after e13.5 (Fig. S5C) 
Next, we considered recruitment of pericytes that normally envelop nascent microvessels, span endothelial cell junctions, and embed within the vascular basement membrane to provide structural support and signals that control endothelial cell growth versus quiescence (21) . In the pituitary, rostral neural crest-derived mesenchyme gives rise to pericytes that surround anterior lobe capillaries (22) . At e13.5, we coimmunostained with the pericyte marker PDGF receptor β (PDGFRβ) and vascular endothelial growth factor receptor 2 (VEGFR2) which labels endothelial cells (21) . We observed densely packed PDGFRβ(+) cells surrounding the developing glands, and in controls, pericytes were associated with invading endothelial cells. In Itgb1 f/f ; Pitx1-cre pituitaries, however, endothelial cells lacked associated pericytes at e13.5, and by e14.5, endothelial cells were also absent (Fig. 3 and Fig. S5 D and E) .
A well-characterized mechanism of pericyte recruitment involves secretion of PDGF-B by endothelial tip cells in angiogenic sprouts. Subsequent tethering of secreted PDGF-B to heparan sulfate and heparan sulfate proteoglycans (HSPGs) in the ECM retains it at relatively high local concentrations for binding to PDGFRβ on pericytes. In the absence of PDGF-B signaling, lack of pericyte recruitment has been correlated with increased vessel diameter, hemorrhage, and edema in many tissues (21) . In the pituitary, genetic ablation of neural crest-derived pericytes resulted in vessels that survived and formed lumens but were dilated and leaky (22, 23) . Based on these findings, we examined vascular development in the pituitary glands of PDGFRβ −/− mice (24). At e14.5, immunostaining with VEGFR2 revealed that blood vessels were present but highly dilated, suggesting that PDGF-B signaling plays a role in pericyte recruitment in the embryonic pituitary (Fig. S5F) . By extension, defective PDGF-B signaling may explain failure of pericyte recruitment in e13.5 Itgb1 f/f ; Pitx1-cre pituitaries, but it does not fully explain the absence of endothelial cells observed at e14.5.
Reduced Vessel Density and Lumen Formation in Itgb1
f/f ; Prop1-cre Pituitaries at e14.5. The role of epithelial integrin β1 in later steps in angiogenesis was examined in Itgb1 f/f ; Prop1-cre embryos. Coimmunostaining of CD31 and laminin at e14.5 and e15.5 demonstrated that endothelial cells invaded the anterior lobe and deposited laminin-rich basement membranes equivalently in control and Itgb1 f/f ; Prop1-cre pituitaries (Fig. S6A) . Immunostaining of CD31 and NG2 (Fig. S6B ), or PDGFRβ (Fig. S6C) , demonstrated that pericytes were associated with endothelial cells in Itgb1 f/f ; Prop1-cre pituitary glands at e15.5. We next examined lumen formation. H&E staining at e14.5 detected RBCs in both control and Itgb1 f/f ; Prop1-cre pituitaries in the rostral anterior lobes where endothelial cells first invade. RBCs were also present within the central and caudal anterior lobe in control pituitaries, thus identifying e14.5 as the time at which lumen formation normally begins. In Itgb1 f/f ; Prop1-cre pituitaries, however, RBCs were rarely observed in the central and caudal anterior lobe, suggesting compromised lumen formation and/or reduced vessel number (Fig. S6D) .
To investigate vessel number and lumen formation further, e14.5 coronal sections were immunostained with integrin β1 and CD31. At this stage, cords of invading endothelial cells appeared as tight clusters with or without visible lumens (Fig. 4A and Fig. S6E ). In Itgb1 f/f ; Prop1-cre pituitaries, endothelial cell cluster number was reduced by >50%, suggesting a defect in vessel branching (Fig. 4 B  and D) , and the number with a detectable lumen was ∼25% of normal ( Fig. 4 C and D) . Within clusters that formed lumens at e14.5, median lumen diameter in controls was 6.0 μm, with a range from 2.0 μm to 14.9 μm, but it was only 3.5 μm, with a range from 1.1 μm to 10.1 μm in Itgb1 f/f ; Prop1-cre pituitary glands (Fig. 4E and Fig. S6 E and F) . Hence, loss of epithelial integrin β1 by e14.5 resulted in a decreased number of nascent blood vessels with compromised lumen formation. ; Pitx1-cre mice, e10.5 inactivation of integrin β1 provided a homogeneous population of epithelial cells before initiation of angiogenesis at e13.5. We hypothesized that profiling gene expression at e12.5 in cells that uniformly lacked integrin β1 might provide insight into why angiogenesis failed (Fig. 5A) . Massively parallel RNA-sequencing (RNA-seq) was used to compare the transcriptomes of pituitaries dissected at e12. ; Pitx1-cre RNA samples was validated by viewing sequence tags mapped to the Itgb1 locus (Fig. S7A) .
In Itgb1 f/f ; Pitx1-cre pituitaries, RNA-seq data revealed significantly altered expression (>1.5-fold change) of 1,138 genes (P ≤ 0.01). Expression of 496 genes decreased, and expression of 642 genes increased. Gene ontology analysis revealed changes in both cell-intrinsic and cell-extrinsic gene programs (Fig. 5B ). Heat maps representing selected genes showed explicit membership in four categories of extrinsic factors that may be involved in the non-cellautonomous effect of epithelial cells on angiogenesis. Genes in these categories included components of the ECM, ECM-associated intercellular signaling molecules, several integrin subunits that heterodimerize with integrin β1 (α3, α7, and α9), and a number of disintegrins/metalloproteinases (Fig. 5C) . Curiously, integrins α3β1 and α7β1 bind specifically to laminin, a major component of vascular basement membranes in the embryonic pituitary (3, 14) .
In the ECM category, expression of the core matrisome components fibronectin (FN), six of 28 collagens, and laminin C1 were significantly altered (8) (Fig. 5C) . FN, which is important for embryonic blood vessel morphogenesis, was the most down-regulated, as seen in mice null for integrin α5 (25, 26) . In addition to stimulating expression of FN, integrin α5β1 is required to bind to FN to initiate assembly of the fibrillar matrix, which functions as a reservoir for locally secreted growth factors such as VEGF-A (8).
Immunohistochemical staining of FN in e12.5 Itgb1 f/f ; Pitx1-cre pituitaries revealed diminished expression along the rostral aspect of the anterior lobe where endothelial cells first invade and a punctate, rather than fibrillar, pattern, suggesting diminished integrin β1-induced conversion of compact FN into extended fibrils (Fig. S7B) .
In the retina, FN deposited by astrocytes localized VEGF-A ahead of migrating tip cells in angiogenic sprouts (27) . Interestingly, VEGF-A is highly expressed in e14.5 embryonic pituitaries (GenePaint.org) and has been implicated in vascular development in the mouse pituitary gland (28) . Based on these findings, we asked if deletion of VEGF-A might phenocopy the absence of endothelial cells observed in e14.5 Itgb1 f/f ; Pitx1-cre pituitaries. VEGF-A f/f ; Pitx1-cre mice were generated, and pituitaries were immunostained with VEGFR2 and PDGFRβ, but angiogenesis appeared normal at e14.5 (29) (Fig. S7C) . One explanation is that VEGF-A may have escaped deletion in a small percentage of cells such as folliculostellate cells (30) . However, given that Pitx1-cre deleted Itgb1 flox alleles with complete penetrance in the mouse pituitary ; Prop1-cre. Whisker ends represent minimum and maximum data points. ****P < 0.0001 determined by Mann-Whitney test. Magnified images are provided in Fig. S5 E and F. gland, it seems unlikely. A more probable explanation is functional redundancy with VEGF-C, which is also highly expressed in the e14.5 pituitary gland (GenePaint.org) and can bind to VEGFR2 (Fig. S7D ).
Discussion
Our findings provide unambiguous evidence of critical non-cellautonomous roles for integrin β1 in vascular development that contrast with numerous reports of other tissue-specific integrin β1 knockouts (31) (32) (33) (34) , and complement established vascular cellautonomous functions of integrin β1 (9-13). Our data support the idea that there are distinct tissue and temporal context-dependent requirements for specific integrin heterodimers in vascular development (11) . Indeed, the only other well-defined example of a non-cell-autonomous role played by integrins in vascular development involves integrin αvβ8 in the CNS and retina, where failure to activate latent ECM-bound TGF-β was an underlying cause of the observed vascular defects (35, 36) . Interestingly, the palate defect in the Pitx1-cre; Itgb1 f/f embryos phenocopies double-knockouts of integrin β6/β8 and single-knockouts of TGF-β3, suggesting integrin β1-dependent TGF-β signaling in the palate (37, 38) .
We observed that multiple steps in developmental angiogenesis required expression of epithelial integrin β1 in the embryonic pituitary gland. In its absence, expression of genes encoding core components of the ECM, ECM-associated signaling factors, and remodeling molecules are changed, suggesting that alterations in ECM function might underlie the observed phenotypes. In addition, integrin β1 initiates self-assembly of secreted FN dimers into a multimeric fibrillar matrix that subsequently affects formation of collagen fibrils (8) . Ultimately, changes in the deposition and assembly of the ECM in the absence of epithelial integrin β1 may have altered its ability to provide structural support, and to function as a scaffold that binds and presents secreted growth factors to vascular cells (8) .
PDGF-B, VEGF, and TGF-β are secreted growth factors that regulate blood vessel development through binding to the ECM in a manner that controls their local concentration and bioavailability (8) . Examination of PDGFRβ-null mice indicated that PDGF-B signaling plays a role in pericyte recruitment in the embryonic pituitary gland. Failure to recruit pericytes, however, led to dilated and leaky vessels but not to the loss of endothelial cells observed in the e14.5 Pitx1-cre; Itgb1 f/f pituitaries (21) . Therefore, additional endothelial cell migration, retention, and/or survival signals must also be compromised. Candidate molecules with such function include VEGF-A and VEGF-C, both of which are highly expressed in the embryonic pituitary gland at e14.5. Deletion of VEGF-A alone in VEGF-A f/f ; Pitx1-cre pituitaries surprisingly showed no effect on endothelial cell invasion or pericyte recruitment, and so raised the possibility of compensation by VEGF-C (39). Interestingly, vascularization defects in the embryonic pituitaries of Prop df/df mice (Ames dwarf) that lack the transcription factor, Prop1, have been attributed to altered expression of VEGF-A protein (28) . Although this finding appeared to contrast with the apparent lack of vascular phenotype in our deletion of VEGF-A, it was separately noted that VEGF-C mRNA was also decreased more than threefold in pituitaries from e12.5 Prop1 knockout mice (Fig. S8) . Together, these data suggest that simultaneous down-regulation of both VEGF-A and VEGF-C may cause the vascular defects seen in the embryonic pituitary glands of mice lacking Prop1. In the case of Pitx1-cre; Itgb1 f/f mice, and perhaps Prop1-cre; Itgb1 f/f mice, interaction of both VEGF-A and VEGF-C with the ECM would likely be compromised. This outcome suggests that the absence of vasculature observed with inactivation of pituitary epithelial integrin β1 might result from the failure of a series of signals, including PDGF-B, VEGF-A, and VEGF-C, that, together, orchestrate vascular development.
In total, our data support the conclusion that integrin β1 in the epithelial cells of the embryonic pituitary gland is required for normal expression of numerous ECM and associated molecules that function in critical non-cell-autonomous roles during vascular development. In addition, the cell-autonomous function of integrin β1 in epithelial cells is required for normal expression of endocrine cell terminal differentiation markers such as GH and Prl. Together, these effects reveal that epithelial integrin β1 coordinates development of the embryonic pituitary gland and its invading vascular system. Whether reciprocal heterotypic interactions between the parenchyma and nascent vasculature extend beyond development of a circulatory system that delivers regulatory signals to hormone-producing cells remains an open question.
Materials and Methods
Conditional Deletions of the Itgb1 and VEGF-A Genes. 
